Previous 10 | Next 10 |
Tenax Therapeutics (NASDAQ:TENX): Q2 GAAP EPS of -$0.10. Revenue of $2.2M Press Release For further details see: Tenax Therapeutics reports Q2 results
Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today reported financial results for the second quarter of 2021 an...
Levosimendan was shown to Reduce Stressed Blood Volume (SBV), a Novel and Highly Relevant Mechanism of Action for PH-HFpEF Patients Stressed Blood Volume Reductions Accompany Previously Reported Improvements in Important Cardiovascular Hemodynamic Measurements Reduct...
Event to Focus on Current Treatment Landscape and Therapeutic Potential of Levosimendan in PH-HFpEF Monday, August 16th @ 10AM ET Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing produc...
Tenax Therapeutics (TENX) announces that effective July 13, 2021, Mr. Anthony A. DiTonno will retire as Chief Executive Officer ((CEO)) and Director of the Company, following a successful decade of service with the Company.The Board has appointed Mr. Christopher T. Giordano to serve as CEO an...
– Anthony DiTonno Retires from Tenax; Christopher Giordano Appointed as CEO – Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company that address cardiovascular and pulmonary diseases with high unmet medical need, today announced a CEO tran...
SeaChange International (SEAC) +26% on insider buying.ReTo Eco-Solutions (RETO) +21% after announcing new iron tailings project.Achieve Life Sciences (ACHV) +17%.Jiuzi Holdings, Inc. (JZXN) +15%.Tiziana Life Sciences PLC (TLSA) +11% on agreement with FHI Clinical to conduct Pha...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, traders! We’re starting off the day with a look at the biggest pre-market stock market movers for Wednesday. That includes those that are seeing the largest gains and losses in early morning trading. ...
Tenax Therapeutics (TENX) to join the Russell Microcap Index at the conclusion of the 2021 Russell indexes annual reconstitution effect after the U.S. market opens on June 28.“Our inclusion in the Russell Microcap Index comes at an exciting time for our company, as we expect to advance...
Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, is set to join the Russell Microcap® Index at the conclusion ...
News, Short Squeeze, Breakout and More Instantly...
Tenax Therapeutics Inc. Company Name:
TENX Stock Symbol:
NASDAQ Market:
Tenax Therapeutics Inc. Website:
Currently Enrolling Patients in Phase 3 LEVEL Study with 24 Investigative Sites Initiated Secured Global Development and Commercial Rights to Levosimendan for Treatment of PH-HFpEF Expanded Intellectual Property Estate for Levosimendan with Issuance of New U.S. Patent ...
Broadens IP protection for oral (TNX-103), IV, and subcutaneous use of levosimendan, and its active metabolites (OR1896 and OR1855), in PH-HFpEF Provides U.S. intellectual property (IP) protection until December 2040, and may qualify for additional U.S. patent term extension (PTE) beyond ...